Advertisement
New Zealand markets closed
  • NZX 50

    11,783.39
    -26.09 (-0.22%)
     
  • NZD/USD

    0.6109
    +0.0007 (+0.12%)
     
  • NZD/EUR

    0.5637
    -0.0001 (-0.01%)
     
  • ALL ORDS

    7,999.20
    -83.90 (-1.04%)
     
  • ASX 200

    7,727.60
    -84.20 (-1.08%)
     
  • OIL

    76.28
    -0.59 (-0.77%)
     
  • GOLD

    2,339.30
    +2.10 (+0.09%)
     
  • NASDAQ

    18,623.39
    -81.82 (-0.44%)
     
  • FTSE

    8,309.70
    -29.53 (-0.35%)
     
  • Dow Jones

    39,065.26
    -605.78 (-1.53%)
     
  • DAX

    18,618.77
    -72.55 (-0.39%)
     
  • Hang Seng

    18,608.94
    -259.77 (-1.38%)
     
  • NIKKEI 225

    38,646.11
    -457.11 (-1.17%)
     
  • NZD/JPY

    95.8740
    +0.1720 (+0.18%)
     

Is Moderna Building a Respiratory Vaccine Empire?

Is Moderna Building a Respiratory Vaccine Empire?

Moderna (NASDAQ: MRNA) made a name for itself through its coronavirus vaccine. The vaccine has generated billions of dollars in earnings over the past two years. Now, however, demand from that star product is on the decline -- and Moderna faces a serious drop in revenue.